TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17959576

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care services (usual care plus standardized services from a clinical pharmacist, including an initial comprehensive in-home medication assessment and two follow-up visits)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Usual care (services typically provided by the visiting nurses association)
Number of subjects: 154
Study: 15173680

Group type: EXPERIMENTAL
Intervention: Music listening
Number of subjects: 0
Study: 15463834

Group type: EXPERIMENTAL
Intervention: Tobramycin nebuliser solution (TNS) 300 mg by aerosol twice daily (b.i.d.)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396
Study: 9828870

Group type: EXPERIMENTAL
Intervention: Homeopathy treatment for warts
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo treatment for warts
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Surgical procedures during waxing moon
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surgical procedures during waning moon
Number of subjects: 60
Study: 10142083

Group type: EXPERIMENTAL
Intervention: Automated Case Management System/Community Based Care Coordination Project
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Care coordination
Number of subjects: 0
Study: 2483572

Group type: EXPERIMENTAL
Intervention: Nitrendipine (10 mg once daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nitrendipine (10 mg twice daily)
Number of subjects: 30
Study: 1053442

Group type: EXPERIMENTAL
Intervention: RAST (Phadebas)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Prick test
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: RAST
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Nasal test
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: History of hay fever
Number of subjects: 141
Study: 30540355

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13885

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13885

Group type: EXPERIMENTAL
Intervention: Postrandomization MI
Number of subjects: 13885
Study: 28838589

Group type: EXPERIMENTAL
Intervention: Early mobilization (EM) protocol consisting of mobilization from bed in the first 3 days after surgery in the morning and evening.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group mobilized from bed on the third postoperative day according to hospital routine.
Number of subjects: 100
Study: 26372934

Group type: EXPERIMENTAL
Intervention: Prenatal Motivational Interviewing (MI)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Prenatal Health Education (HE)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Postpartum Motivational Interviewing (MI)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Postpartum Health Education (HE)
Number of subjects: 400
Study: 23384381

Group type: EXPERIMENTAL
Intervention: Beer (alcohol condition)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Water (alcohol-free condition)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: BAC estimates (calculated formula)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: BAC estimates (breath alcohol device)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gender (female participants)
Number of subjects: 40
Study: 20535606

Group type: EXPERIMENTAL
Intervention: Bazedoxifene 20 mg
Number of subjects: 7492

Group type: EXPERIMENTAL
Intervention: Bazedoxifene 40 mg
Number of subjects: 7492

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7492
Study: 18723413

Group type: EXPERIMENTAL
Intervention: Magnetic positioning device (MP) assisted colonoscopy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard colonoscopy (SC)
Number of subjects: 38
Study: 17106318

Group type: EXPERIMENTAL
Intervention: Betaxolol hydrochloride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended-release metoprolol tartrate
Number of subjects: 0
Study: 12713450

Group type: EXPERIMENTAL
Intervention: CEE + MPA
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 10878702

Group type: EXPERIMENTAL
Intervention: Postprandial changes in glucose, insulin, triglyceride, and non‐esterified fatty acids (NEFA) after consuming a test meal containing 45% fat.
Number of subjects: 40
Study: 8933487

Group type: EXPERIMENTAL
Intervention: 5.5% CHO-electrolyte solution (E)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 6.9% CHO-electrolyte solution (L)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 11
Study: 1559512

Group type: EXPERIMENTAL
Intervention: MUFA diet (olive oil)
Number of subjects: 11

Group type: COMPARATOR
Intervention: SAFA diet (butter)
Number of subjects: 11
Study: 3158183

Group type: EXPERIMENTAL
Intervention: Nafazatrom (1.2 gm)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30643620

Group type: EXPERIMENTAL
Intervention: Web-based videoconference meeting via Google Hangouts
Number of subjects: 133

Group type: COMPARATOR
Intervention: In-person meeting
Number of subjects: 133
Study: 27702847

Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation (PVI) alone
Number of subjects: 35
Study: 26512712

Group type: EXPERIMENTAL
Intervention: Immediate intervention (home-based lifestyle counseling)
Number of subjects: 641

Group type: COMPARATOR
Intervention: 12-month-wait-listed control arm
Number of subjects: 641
Study: 21114603

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 50 mg with pioglitazone 45 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 20 mg with metformin 1000 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 20 mg with glimepiride 4 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 20 mg with sitagliptin 100 mg
Number of subjects: 60
Study: 19236394

Group type: EXPERIMENTAL
Intervention: Individualized literacy instruction
Number of subjects: 461

Group type: COMPARATOR
Intervention: Comparison instruction
Number of subjects: 461
Study: 17096386

Group type: EXPERIMENTAL
Intervention: CCAP intervention (combined cognitive‐behavioral therapy and pharmacotherapy)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 232
Study: 15082132

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (Dysport) 500 mouse units
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 11464259

Group type: COMPARATOR
Intervention: Hypertensive individuals (dietary sodium intake)
Number of subjects: 2068

Group type: COMPARATOR
Intervention: Hypertensive women (dietary sodium-to-potassium ratio)
Number of subjects: 2068

Group type: EXPERIMENTAL
Intervention: Age, body mass index, overweight, family history of hypertension
Number of subjects: 2068

Group type: EXPERIMENTAL
Intervention: Dietary sodium intake and dietary sodium-to-potassium ratio
Number of subjects: 2068

Group type: EXPERIMENTAL
Intervention: Education level in women
Number of subjects: 2068

Group type: EXPERIMENTAL
Intervention: Commuting physical activity in men
Number of subjects: 2068
Study: 9820380

Group type: EXPERIMENTAL
Intervention: PyloriTek test in cases without eradication therapy
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: PyloriTek test in cases with eradication therapy
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: PyloriTek test used more than 4 months after eradication therapy
Number of subjects: 163
Study: 8085448

Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure (N‐CPAP)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Mechanical ventilation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both groups (N‐CPAP and ventilator)
Number of subjects: 15
Study: 2627407

Group type: EXPERIMENTAL
Intervention: 20 micrograms/kg butorphanol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 40 micrograms/kg butorphanol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2 micrograms/kg fentanyl
Number of subjects: 60
Study: 9636

Group type: EXPERIMENTAL
Intervention: Flurazepam 15 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amylobarbitone sodium 100 mg
Number of subjects: 0
Study: 31119709

Group type: EXPERIMENTAL
Intervention: Web-based education group
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Brochure group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 31583252

Group type: EXPERIMENTAL
Intervention: 800 IU of vitamin D3 daily for 30 consecutive months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CYP27B1 (rs10877012) G/T genotype
Number of subjects: 0
Study: 28353655

Group type: EXPERIMENTAL
Intervention: High Meat Diet (HMD)
Number of subjects: 51

Group type: COMPARATOR
Intervention: High Whole Grain Diet (HWD)
Number of subjects: 51
Study: 25045035

Group type: EXPERIMENTAL
Intervention: Playing a turned-on musical keyboard (audio feedback present)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Performing exercises on a turned-off musical keyboard (audio feedback absent)
Number of subjects: 19
Study: 23217660

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 21535876

Group type: EXPERIMENTAL
Intervention: Home-based intervention for preventing and managing illnesses related to HIV, TB, alcohol use, and malnutrition in pregnant mothers and their infants.
Number of subjects: 1062
Study: 20024744

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) sessions by peer outreach workers (POW)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Motivational Interviewing (MI) sessions by masters level staff (MLS)
Number of subjects: 87
Study: 16446322

Group type: EXPERIMENTAL
Intervention: Cisplatin 80 mg/m2 intravenously on day 1
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Cisplatin 80 mg/m2 intravenously on day 1 with raltitrexed 3 mg/m2
Number of subjects: 250
Study: 15471393

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 73
Study: 11273920

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 23

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 23
Study: 9435365

Group type: EXPERIMENTAL
Intervention: Group III (obese with Central Obesity Predominance, N = 23)
Number of subjects: 31
Study: 8300711

Group type: EXPERIMENTAL
Intervention: Below-knee elastic stockings
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no elastic compression)
Number of subjects: 38
Study: 6410104

Group type: EXPERIMENTAL
Intervention: Fast neutron therapy (average energy, 6 MeV)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Linac x-ray therapy (10 MV)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Fast neutron therapy
Number of subjects: 49

Group type: COMPARATOR
Intervention: Linac x-ray therapy
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Fast neutron therapy and Linac x-ray therapy
Number of subjects: 49
Study: 31217549

Group type: EXPERIMENTAL
Intervention: Good sleep quality
Number of subjects: 3832
Study: 28280333

Group type: EXPERIMENTAL
Intervention: Acupuncture plus artificial tears (AC + AT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Artificial tears (AT) only
Number of subjects: 28
Study: 26204126

Group type: EXPERIMENTAL
Intervention: Vaginal ring
Number of subjects: 50

Group type: COMPARATOR
Intervention: COC pills
Number of subjects: 50
Study: 23986022

Group type: EXPERIMENTAL
Intervention: KidScents™ toothpaste
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Browning B& B™ toothpaste
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Wysong Probiodent™ toothpaste
Number of subjects: 20

Group type: COMPARATOR
Intervention: Water (positive control)
Number of subjects: 20
Study: 22453191

Group type: EXPERIMENTAL
Intervention: 3 mg intranasal midazolam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 6 mg intranasal midazolam
Number of subjects: 12

Group type: COMPARATOR
Intervention: 5 mg intravenous midazolam
Number of subjects: 12
Study: 19236375

Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (IN‐DDAVP)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Comparison of TA to IN‐DDAVP
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both IN‐DDAVP and TA
Number of subjects: 116
Study: 17577015

Group type: EXPERIMENTAL
Intervention: Boost dose of 16 Gy (2,661 patients)
Number of subjects: 5318

Group type: COMPARATOR
Intervention: No boost dose (2,657 patients)
Number of subjects: 5318

Group type: EXPERIMENTAL
Intervention: Both arms (boost and no boost)
Number of subjects: 5318
Study: 16796540

Group type: EXPERIMENTAL
Intervention: AeroChamber Max VHC (out-of-the-package)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AeroChamber Max VHC (pre-washed/rinsed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ProChamber VHC (pre-washed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OptiChamber Advantage VHC (pre-washed)
Number of subjects: 0
Study: 15011204

Group type: COMPARATOR
Intervention: Standard Epley maneuver
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Augmented Epley (additional 45 degrees head rotation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home Instruction (instructions about sleeping position)
Number of subjects: 0
Study: 10368838

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: HRT
Number of subjects: 100
Study: 8933789

Group type: EXPERIMENTAL
Intervention: MRI (T2-weighted SE MRI)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Morphologic assessment
Number of subjects: 152
Study: 1896820

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: MCO responders
Number of subjects: 115
Study: 6336941

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pentazocine
Number of subjects: 20
Study: 31394283

Group type: EXPERIMENTAL
Intervention: Antibiotics plus albumin (study group)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Antibiotics alone (control group)
Number of subjects: 118
Study: 30828917

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 1997

Group type: COMPARATOR
Intervention: Oral antidiabetic drugs (OADs)
Number of subjects: 1997
Study: 28459406

Group type: EXPERIMENTAL
Intervention: MPRDT-FOB
Number of subjects: 240

Group type: COMPARATOR
Intervention: PDT
Number of subjects: 240

Group type: COMPARATOR
Intervention: MPDT
Number of subjects: 240

Group type: COMPARATOR
Intervention: PDT-FOB
Number of subjects: 240
Study: 24811050

Group type: EXPERIMENTAL
Intervention: Micropulse cyclophotocoagulation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Continuous wave cyclophotocoagulation
Number of subjects: 48
Study: 23833868

Group type: EXPERIMENTAL
Intervention: Loss-framed message in white text on a red background
Number of subjects: 180

Group type: COMPARATOR
Intervention: Gain-framed message
Number of subjects: 180
Study: 21696072

Group type: EXPERIMENTAL
Intervention: Intra-coronary bone marrow mononuclear cell (BMC) transplantation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study: 19536417

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (30 mg/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (no zinc supplementation)
Number of subjects: 61
Study: 17047540

Group type: EXPERIMENTAL
Intervention: BMP/compression resistant matrix
Number of subjects: 98

Group type: COMPARATOR
Intervention: Iliac crest bone graft
Number of subjects: 98
Study: 12718221

Group type: EXPERIMENTAL
Intervention: Three-stage rehabilitation (outpatient clinic-hospital-sanatorium) for 9 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rehabilitation only in outpatient clinic
Number of subjects: 0
Study: 10671903

Group type: EXPERIMENTAL
Intervention: MDMA 50 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: MDMA 100 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: MDMA 150 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: MDMA 75 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: MDMA 125 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: MDMA (all doses tested)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: MDMA (general conclusion)
Number of subjects: 14
Study: 9348549

Group type: EXPERIMENTAL
Intervention: m-chlorophenylpiperazine (mCPP) 0.1 mg/kg during TRP depletion
Number of subjects: 22

Group type: COMPARATOR
Intervention: m-chlorophenylpiperazine (mCPP) 0.1 mg/kg during sham depletion
Number of subjects: 22
Study: 8250285

Group type: EXPERIMENTAL
Intervention: Surgical ligation
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Angiographic embolization
Number of subjects: 71
Study: 4083102

Group type: EXPERIMENTAL
Intervention: Exposure to smoking cues
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nonexposure to smoking cues
Number of subjects: 48
Study: 28686073

Group type: EXPERIMENTAL
Intervention: 180 min of normobaric poikilocapnic hypoxia (capillary oxygen saturation 70-75%)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham (normoxia)
Number of subjects: 15
Study: 29352713

Group type: EXPERIMENTAL
Intervention: Sipuleucel-T immunotherapy
Number of subjects: 94
Study: 26661520

Group type: EXPERIMENTAL
Intervention: Pre‐wounded sites
Number of subjects: 10

Group type: COMPARATOR
Intervention: Routine graft sites
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Routine and pre‐wounded sites
Number of subjects: 10
Study: 24675915

Group type: EXPERIMENTAL
Intervention: High-frequency TENS (HFT) (100 Hz; 100 µs)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Low-frequency TENS (LFT) (5 Hz; 100 µs)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (PT)
Number of subjects: 33
Study: 22648716

Group type: EXPERIMENTAL
Intervention: Glucose solution with alcohol (21 g alcohol, 25 g carbohydrates)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Beer (4.5% alcohol by volume, 25 g carbohydrates)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nonalcoholic beer (25 g carbohydrates)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Reference glucose solution (25 g carbohydrates)
Number of subjects: 10
Study: 20300014

Group type: EXPERIMENTAL
Intervention: High branched chain amino acids (BCAA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 17098331

Group type: EXPERIMENTAL
Intervention: Levodopa (100mg) plus carbidopa (25mg) during training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 15972322

Group type: EXPERIMENTAL
Intervention: Oral vitamin C supplementation (250 mg three times per week for 2 months)
Number of subjects: 33
Study: 11253577

Group type: EXPERIMENTAL
Intervention: Self-reported adherence to PEFR monitoring
Number of subjects: 42

Group type: COMPARATOR
Intervention: Electronically monitored adherence to PEFR monitoring
Number of subjects: 42
Study: 9731680

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass with 75 cm limb for BMI ≤ 51 kg/m2 (n = 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass with 150 cm limb for BMI ≤ 51 kg/m2 (n = 16)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass with 150 cm limb for BMI ≥ 51 kg/m2 (n = 18)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass with 250 cm limb for BMI ≥ 51 kg/m2 (n = 6)
Number of subjects: 60
Study: 8015757

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed placement of epidural until 5 cm cervical dilatation or greater
Number of subjects: 0
Study: 2538962

Group type: EXPERIMENTAL
Intervention: Simultaneous radiation and chemotherapy (group 1)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Sequential chemotherapy followed by radiation (group 2)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Complete remission patients
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Chemotherapy responders in group 2
Number of subjects: 135
Study: 30947092

Group type: EXPERIMENTAL
Intervention: Somatization Disorder (SD)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Socio-clinical factors
Number of subjects: 422
Study: 28756830

Group type: EXPERIMENTAL
Intervention: Chronic allergies
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Warnings on packages
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Intention to quit in 2 months
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Low-nicotine dependent smokers
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Higher-motivated smokers
Number of subjects: 382
Study: 25598105

Group type: EXPERIMENTAL
Intervention: Maximal esophageal dissection and mobilization (MAX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimal esophageal dissection and mobilization (MIN)
Number of subjects: 0
Study: 25008011

Group type: EXPERIMENTAL
Intervention: Salacia reticulata and Vitamin D₃ (200 mg of Salacia reticulata and 1.6 µg Vitamin D₃ 3 times/day with meals)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lifestyle and fitness training for 4 weeks
Number of subjects: 40
Study: 21808660

Group type: EXPERIMENTAL
Intervention: Changes in pitch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in volume
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Automatic auditory processes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiological processes encoding sound pitch and intensity
Number of subjects: 0
Study: 18516403

Group type: EXPERIMENTAL
Intervention: Spironolactone 25mg/qd (n=11)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No spironolactone (n=11)
Number of subjects: 22
Study: 16873329

Group type: EXPERIMENTAL
Intervention: Custom-designed dental scaling instruments with a large diameter (10 mm) and light weight (15 g)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Custom-designed dental scaling instruments with diameters larger than 10 mm
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Custom-designed dental scaling instruments lighter than 15 g
Number of subjects: 24
Study: 12615252

Group type: EXPERIMENTAL
Intervention: Oral magnesium 15 mmol twice daily (Magnosolv‐Granulat, total magnesium 365 mg provided as magnesium citrate)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187